ESTIMATES OF CARDIOVASCULAR RISK REDUCTION WITH NIACIN EXTENDED-RELEASE AND SIMVASTATIN IN MIXED DYSLIPIDEMIA

被引：0
|
作者：
Insull, W. [1 ]
Jiang, P. [2 ]
Tian, M. [2 ]
Thakkar, R. [2 ]
Padley, R. [2 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Abbott, Abbott Pk, IL USA
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2009年 / 10卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Estimates of Cardiovascular Risk Reduction With Niacin Extended-Release and Simvastatin in Mixed Dyslipidemia
    Insull, William, Jr.
    Jiang, Ping
    Tian, Min
    Thakkar, Roopal B.
    Padley, Robert J.
    JOURNAL OF CARDIOVASCULAR NURSING, 2010, 25 (05) : 363 - 363
  • [2] Niacin Extended-Release/Simvastatin
    Mark Sanford
    Monique P. Curran
    Drugs, 2008, 68 : 2373 - 2386
  • [3] Niacin Extended-Release/Simvastatin
    Sanford, Mark
    Curran, Monique P.
    DRUGS, 2008, 68 (16) : 2373 - 2386
  • [4] Effects of Extended-Release Niacin and Extended-Release Niacin/Laropiprant on the Pharmacokinetics of Simvastatin in Healthy Subjects
    Lauring, Brett
    Dishy, Victor
    De Kam, Pieter-Jan
    Crumley, Tami
    Wenning, Larissa
    Liu, Fang
    Sisk, Christine
    Wagner, John
    Lai, Eseng
    AMERICAN JOURNAL OF THERAPEUTICS, 2015, 22 (05) : 367 - 376
  • [5] Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia
    Ballantyne, Christie
    Gleim, Gilbert
    Liu, Nancy
    Sisk, Christine McCrary
    Johnson-Levonas, Amy O.
    Mitchel, Yale
    JOURNAL OF CLINICAL LIPIDOLOGY, 2012, 6 (03) : 235 - 243
  • [6] Flushing Profile of Extended-Release Niacin/Laropiprant Versus Gradually Titrated Niacin Extended-Release in Patients With Dyslipidemia With and Without Ischemic Cardiovascular Disease
    Maccubbin, Dorbie
    Koren, Michael J.
    Davidson, Michael
    Gavish, Dov
    Pasternak, Richard C.
    Macdonell, Geraldine
    Mallick, Madhuja
    Sisk, Christine McCrary
    Paolini, John F.
    Mitchel, Yale
    AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (01): : 74 - 81
  • [7] Population-based response estimates for extended-release niacin and extended-release niacin/lovastatin versus other dyslipidemia therapy in patients with the metabolic syndrome
    Stanek, EJ
    Quimbo, R
    Cziraky, MJ
    Charland, SL
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) : E84 - E84
  • [8] Safety of extended-release niacin/laropiprant in patients with dyslipidemia
    McKenney, James
    Bays, Harold
    Koren, Michael
    Ballantyne, Christie M.
    Paolini, John F.
    Mitchel, Yale
    Betteridge, Abigaile
    Kuznetsova, Olga
    Sapre, Aditi
    Sisk, Christine McCrary
    Maccubbin, Darbie
    JOURNAL OF CLINICAL LIPIDOLOGY, 2010, 4 (02) : 105 - 112
  • [9] Combination Niacin Extended-Release and Simvastatin Treatment Improves Atherogenic Lipoprotein Particle Profile Compared With Atorvastatin Monotherapy in Mixed Dyslipidemia
    Insull, William, Jr.
    Toth, Peter P.
    Superko, H. Robert
    Thakkar, Roopal B.
    Jiang, Ping
    Parreno, Rhea
    Padley, Robert J.
    JOURNAL OF CARDIOVASCULAR NURSING, 2010, 25 (05) : 363 - 364
  • [10] SAFETY PROFILE OF EXTENDED-RELEASE NIACIN/LAROPIPRANT IN PATIENTS WITH DYSLIPIDEMIA
    McKenney, J.
    Bays, H.
    Koren, M.
    Ballantyne, C.
    Maccubbin, D.
    Mitchel, Y.
    Betteridge, A.
    Kuznetsova, O.
    Sapre, A.
    Sisk, C.
    Paolini, J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 194 - 195
12345